Michael Freeman
Company: Raymond James
Job title: Equity Research Associate
Bio:
Michael is an equity research associate covering healthcare and biotechnology at Raymond James with a special practice focused on the development of cannabinoid-oriented technologies. Michael holds an MASc in chemical engineering from the University of Toronto, where he specialized in chemotherapeutic nanomedicines and their encompassing clinical and regulatory environments. Michael also holds a BASc in biochemical engineering from Queen’s University, where his work concentrated on industrial scale chemical and biological processes, with a special focus on polymer reaction engineering and synthetic biology (i.e. biosynthesis via genetic and metabolic engineering). Prior to joining Raymond James Ltd., Michael’s roles included Senior Equity Research Associate—Healthcare & Biotechnology with Paradigm Capital, Process Engineer with WSP Global, and Science Journalist with the University Health Network.
Seminars:
Live Presenter Q&A 11:40 am - 12:00 pm
day: Day One
The Evolving Cannabinoid API Market: Disruption for Some, Normal Course for Most 10:20 am - 10:40 am
Download The Full Event Guide Read more
day: Day One